On July 15, 2021, HeartFlow announced a definitive agreement with Longview Acquisition Corp. II to become a publicly traded company.

HeartFlow is also supported by recognized and highly-regarded investors that share a track record of backing successful, mission-driven companies that are positively changing the healthcare landscape.

For investor inquiries, please email:

To view our disclaimers regarding the business combination, forwarding-looking statements, or solicitation, please click here.

123586370 v1